Amazon holding exploratory talks with generic-drug makers

One of the people said the conversations are about Amazon taking a role in drug purchasing, potentially disrupting a space at This specific point dominated by distributors McKesson, AmerisourceBergen in addition to Cardinal Health. Generics manufacturers are eager to establish a relationship with Amazon as part of 2018 business plans, the person said.

Stocks of drug distributors in addition to others from the pharmaceutical supply chain, such as pharmacies in addition to pharmacy benefits managers, have been pressured by the specter of Amazon entering the space.

Some from the industry have doubted the tech giant will make the decision to compete in pharmacy; at the Forbes Healthcare Summit Wednesday, Walgreens Boots Alliance CEO Stefano Pessina suggested the regulatory hurdles may be too high.

“I believe in which they will not come in an industry so complicated as our industry,” Pessina said. “I believe from the end they will use their technology in a different way.”

the item’s a topic of intense speculation on Wall Street in addition to from the pharmaceutical industry. Many drug company executives, including the CEOs of Pfizer in addition to Allergan, were asked about the prospect of working with Amazon on their most recent quarterly earnings conference calls. They responded enthusiastically however said no formal discussions were taking place.

Novartis, Mylan in addition to Amazon declined to comment.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

1 × four =